RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재

      양극성 조증 입원 환자에서 과체중, 비만과 연관 인자 : 예비 연구 = Factors Associated with Overweight and Obesity in Inpatients with Bipolar Mania : A Preliminary Study

      한글로보기

      https://www.riss.kr/link?id=A100815180

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Objective : Being overweight or obesity impairs quality of life and often causes treatment noncompliance in patients with bipolar disorder. This preliminary study evaluated the prevalence of overweight and obesity in inpatients with bipolar mania. Methods : Inpatients with bipolar mania, who were treated with adequate medications at least 4 weeks were included in a retrospective study. The body weight of each patient was measured and the body mass index (BMI) was calculated. Results : Of the 80 patients, 16.4% (N=13) were overweight, and 35.0% (N=28) were obese at discharge. Female patients had higher prevalence rates of overweight and obesity. Being overweight or obesity was associated with the number of previous episodes of depression and combination treatment with atypical antipsychotics and mood stabilizers. Conclusions : Being overweight or obesity is highly prevalent in patients with bipolar mania. Clinicians should pay more attention to weight gain and obesity when prescribing combination therapies. More research is required to identify the impact of specific risk factors for overweight and obesity in patients with bipolar mania.
      번역하기

      Objective : Being overweight or obesity impairs quality of life and often causes treatment noncompliance in patients with bipolar disorder. This preliminary study evaluated the prevalence of overweight and obesity in inpatients with bipolar mania. Met...

      Objective : Being overweight or obesity impairs quality of life and often causes treatment noncompliance in patients with bipolar disorder. This preliminary study evaluated the prevalence of overweight and obesity in inpatients with bipolar mania. Methods : Inpatients with bipolar mania, who were treated with adequate medications at least 4 weeks were included in a retrospective study. The body weight of each patient was measured and the body mass index (BMI) was calculated. Results : Of the 80 patients, 16.4% (N=13) were overweight, and 35.0% (N=28) were obese at discharge. Female patients had higher prevalence rates of overweight and obesity. Being overweight or obesity was associated with the number of previous episodes of depression and combination treatment with atypical antipsychotics and mood stabilizers. Conclusions : Being overweight or obesity is highly prevalent in patients with bipolar mania. Clinicians should pay more attention to weight gain and obesity when prescribing combination therapies. More research is required to identify the impact of specific risk factors for overweight and obesity in patients with bipolar mania.

      더보기

      참고문헌 (Reference)

      1 Fava M, "Weight gain and antidepressants" 61 (61): 37-41, 2000

      2 Kim B, "Weight change in the acute treatment of bipolar I disorder: a naturalistic observational study of psychiatric inpatients" 105 : 45-52, 2008

      3 Behn A, "The obesity epidemic and its cardiovascular consequences" 21 : 353-360, 2006

      4 Allison DB, "The distribution of body mass index among individuals with and without schizophrenia" 60 : 215-220, 1999

      5 Stedman T, "The distribution of adipose tissue in female patients receiving psychotropic drugs" 162 : 249-250, 1993

      6 Kurzthaler I, "The clinical implications of weight gain in schizophrenia" 62 (62): 32-37, 2001

      7 James PT, "The Worldwide Obesity" 9 : 228-233, 2001

      8 Shi H, "Sex differences in the regulation of body weight" 97 : 199-204, 2009

      9 Nemeroff CB, "Safety of available agents used to treat bipolar disorder: focus on weight gain" 64 : 532-539, 2003

      10 Ramacciotti CE, "Relationship between bipolar illness and bingeeating disorders" 135 : 165-170, 2005

      1 Fava M, "Weight gain and antidepressants" 61 (61): 37-41, 2000

      2 Kim B, "Weight change in the acute treatment of bipolar I disorder: a naturalistic observational study of psychiatric inpatients" 105 : 45-52, 2008

      3 Behn A, "The obesity epidemic and its cardiovascular consequences" 21 : 353-360, 2006

      4 Allison DB, "The distribution of body mass index among individuals with and without schizophrenia" 60 : 215-220, 1999

      5 Stedman T, "The distribution of adipose tissue in female patients receiving psychotropic drugs" 162 : 249-250, 1993

      6 Kurzthaler I, "The clinical implications of weight gain in schizophrenia" 62 (62): 32-37, 2001

      7 James PT, "The Worldwide Obesity" 9 : 228-233, 2001

      8 Shi H, "Sex differences in the regulation of body weight" 97 : 199-204, 2009

      9 Nemeroff CB, "Safety of available agents used to treat bipolar disorder: focus on weight gain" 64 : 532-539, 2003

      10 Ramacciotti CE, "Relationship between bipolar illness and bingeeating disorders" 135 : 165-170, 2005

      11 Vestergaard P, "Prospective studies in a lithium cohort, 3: tremor, weight gain, diarrhea, psychological complaints" 78 : 434-441, 1988

      12 Elmslie JL, "Prevalence of over weight and obesity in bipolar patients" 61 : 179-184, 2000

      13 Silverstone T, "Prevalence of obesity in patients receiving depot antipsychotics" 153 : 214-217, 1988

      14 Kim DM, "Prevalence of obesity in Korea" 6 : 117-121, 2005

      15 Fagiolini A, "Prevalence of obesity and weight change during treatment in patients with bipolar I disorder" 63 : 528-534, 2002

      16 Tohen M, "Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial" 162 : 1281-1290, 2005

      17 Tohen M, "Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study" 160 : 1263-1271, 2003

      18 Haslam DW, "Obesity" 366 : 1197-1209, 2005

      19 Wirshing DA, "Novel antipsychotics: comparison of weight gain liabilities" 60 : 358-363, 1999

      20 Grant BF, "Nicotine dependence and psychiatric disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions" 61 : 1107-1115, 2004

      21 Rosenbaum M, "Medical progress: obesity" 337 : 396-407, 1997

      22 Vornik LA, "Management of comorbid bipolar disorder and substance abuse" 67 (67): 24-30, 2006

      23 Marken PA, "Emerging treatments for bipolar disorder: safety and adverse effect profiles" 40 : 276-285, 2006

      24 Phillips GB, "Does insulin resistance, visceral adiposity, or a sex hormone alteration underlie the metabolic syndrome?" 57 : 838-844, 2008

      25 American Psychiatry Association, "Diagnostic and Statistical Manual of Mental Disorder 4th ed" American Psychiatric Press 1994

      26 Elmslie JL, "Determinants of overweight and obesity in patients with bipolar disorder" 62 : 486-491, 2001

      27 Kanazawa M, "Criteria and classification of obesity in Japan and Asia-Oceania" 94 : 1-12, 2005

      28 McElroy SL, "Correlates of overweight and obesity in 644 patients with bipolar disorder" 63 : 207-213, 2002

      29 "Consensus development conference on antipsychotic drugs and obesity and diabetes" 27 : 596-601, 2004

      30 Kruger S, "Comorbidity of binge eating disorder and the partial binge eating syndrome with bipolar disorder" 19 : 45-52, 1996

      31 Keck PE, "Bipolar disorder, obesity, and pharmacotherapy- associated weight gain" 64 : 1426-1435, 2003

      32 Malhotra S, "Associations between metabolic syndrome and psychiatric disorder" 10 : 37-44, 2003

      33 Taylor V, "Associations between bipolar disorder and metabolic syndrome: a review" 67 : 1034-1041, 2006

      34 Reynolds GP, "Association of antipsychotic drug-induced weight gain with a 5-HT2C receptor gene polymorphism" 359 : 2086-2087, 2002

      35 Bowden CL, "A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group" 57 : 481-489, 2000

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2028 평가예정 재인증평가 신청대상 (재인증)
      2022-01-01 평가 등재학술지 유지 (재인증) KCI등재
      2019-01-01 평가 등재학술지 유지 (계속평가) KCI등재
      2016-01-01 평가 등재학술지 선정 (계속평가) KCI등재
      2015-12-01 평가 등재후보로 하락 (기타) KCI등재후보
      2011-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2010-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2008-01-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.29 0.29 0.28
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.25 0.25 0.636 0
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼